The health and human services secretary, Robert F. Kennedy Jr., is accusing the American Academy of Pediatrics of a ...

The AAP has released its own evidence-based immunization schedule with updated recommendations for 3 respiratory viruses.

Respiratory syncytial virus vaccine uptake was low among older veterans, with disparities observed across demographic and social risk factors.

The medical community is waging a public relations fight against Health Secretary Robert F. Kennedy Jr. over COVID-19 ...

The American Academy of Pediatrics is splitting from the federal government in its recommendations on which children should ...

A new study shows that while RSV mostly affects younger kids, the often-overlooked human metapneumovirus also hospitalizes ...

Merck MRK stock has declined 4% since it announced second-quarter results on July 29 before market open. While the company’s ...

Scientists comment on Robert F. Kennedy Jr cancelling funding for mRNA vaccines. Prof Adam Finn, Professor of Paediatrics, University of Bristol, said: ...

Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read an analysis of MRNA stock now.

Moderna, Inc.'s Q2 2025 earnings highlight a steep revenue decline post-pandemic, with just $0.1bn in revenue and a $(0.8bn) net loss. Learn more on MRNA stock here.

Moderna's RSV vaccine for adults aged 60 years and older has been approved ... Moderna continues to make progress on advancing mRNA-4157 in the clinic. In collaboration with Merck, the Phase 3 ...